Apollo Endosurgery APEN Stock
Apollo Endosurgery Price Chart
Apollo Endosurgery APEN Financial and Trading Overview
| Apollo Endosurgery stock price | 10 USD |
| Previous Close | 10 USD |
| Open | 9.93 USD |
| Bid | 9.99 USD x 306100 |
| Ask | 10 USD x 2200 |
| Day's Range | 9.92 - 10 USD |
| 52 Week Range | 3.49 - 10.3 USD |
| Volume | 1.64M USD |
| Avg. Volume | 1.33M USD |
| Market Cap | 579.72M USD |
| Beta (5Y Monthly) | 2.323044 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10 USD |
APEN Valuation Measures
| Enterprise Value | 579.78M USD |
| Trailing P/E | N/A |
| Forward P/E | -11.363636 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.542924 |
| Price/Book (mrq) | 12.886598 |
| Enterprise Value/Revenue | 7.544 |
| Enterprise Value/EBITDA | -23.326 |
Trading Information
Apollo Endosurgery Stock Price History
| Beta (5Y Monthly) | 2.323044 |
| 52-Week Change | 80.18% |
| S&P500 52-Week Change | 2.92% |
| 52 Week High | 10.3 USD |
| 52 Week Low | 3.49 USD |
| 50-Day Moving Average | 9.94 USD |
| 200-Day Moving Average | 7.73 USD |
APEN Share Statistics
| Avg. Volume (3 month) | 1.33M USD |
| Avg. Daily Volume (10-Days) | 334.47K USD |
| Shares Outstanding | 47.55M |
| Float | 39.54M |
| Short Ratio | 0.35 |
| % Held by Insiders | 4.28% |
| % Held by Institutions | 63.40% |
| Shares Short | 462.09K |
| Short % of Float | 1.14% |
| Short % of Shares Outstanding | 0.96% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5.5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -51.83% |
| Operating Margin (ttm) | -36.20% |
| Gross Margin | 55.20% |
| EBITDA Margin | -32.34% |
Management Effectiveness
| Return on Assets (ttm) | -14.38% |
| Return on Equity (ttm) | -84.91% |
Income Statement
| Revenue (ttm) | 76.86M USD |
| Revenue Per Share (ttm) | 1.89 USD |
| Quarterly Revenue Growth (yoy) | 31.80% |
| Gross Profit (ttm) | 42.43M USD |
| EBITDA | -24856000 USD |
| Net Income Avi to Common (ttm) | -39839000 USD |
| Diluted EPS (ttm) | -1.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 57M USD |
| Total Cash Per Share (mrq) | 0.98 USD |
| Total Debt (mrq) | 57.07M USD |
| Total Debt/Equity (mrq) | 175.08 USD |
| Current Ratio (mrq) | 2.349 |
| Book Value Per Share (mrq) | 0.776 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -31262000 USD |
| Levered Free Cash Flow (ttm) | -19844750 USD |
Profile of Apollo Endosurgery
| Country | United States |
| State | TX |
| City | Austin |
| Address | Building 1 |
| ZIP | 78746 |
| Phone | 512 279 5100 |
| Website | https://www.apolloendo.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices for gastrointestinal therapeutic endoscopy. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to suture and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying, which assists the patient in losing weight under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. In addition, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical service providers, hospitals, outpatient surgical centers, clinics, and physicians in the United States, Costa Rica, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Q&A For Apollo Endosurgery Stock
What is a current APEN stock price?
Apollo Endosurgery APEN stock price today per share is 10 USD.
How to purchase Apollo Endosurgery stock?
You can buy APEN shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Apollo Endosurgery?
The stock symbol or ticker of Apollo Endosurgery is APEN.
Which industry does the Apollo Endosurgery company belong to?
The Apollo Endosurgery industry is Medical Devices.
How many shares does Apollo Endosurgery have in circulation?
The max supply of Apollo Endosurgery shares is 57.97M.
What is Apollo Endosurgery Price to Earnings Ratio (PE Ratio)?
Apollo Endosurgery PE Ratio is 0.00000000 now.
What was Apollo Endosurgery earnings per share over the trailing 12 months (TTM)?
Apollo Endosurgery EPS is 0 USD over the trailing 12 months.
Which sector does the Apollo Endosurgery company belong to?
The Apollo Endosurgery sector is Healthcare.
Apollo Endosurgery APEN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}